Dr. C.J. Vaillant Fonds Report issue

Foundation Phase 3

Organization Overview

First Clinical Trial
2020
NCT04647877
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Dr. C.J. Vaillant Fonds